BIRC5 and cancer: However, it should be noted that the survivin localization patterns in the cytoplasm or nucleus may not be a reliable biomarker for clinical outcomes, as it has been linked to both favorable [8,105,106,107] and unfavorable prognosis of cancer patients [108,109,110,111,112,113].